A Study MLN2480 in Combination With MLN0128 or Alisertib, or Paclitaxel, or Cetuximab, or Irinotecan in Adult Participants With Advanced Nonhematologic Malignancies
Clinical trial NCT02327169 · COMPLETED
Trial details
- NCT number
- NCT02327169
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-14
- Primary completion
- 2018-07-02
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.